|
Real-time Estimate
Cboe BZX
15:01:23 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 5.785 USD | +2.39% |
|
-2.81% | -50.70% |
| 08-13 | ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises | MT |
| 08-13 | ARS Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 562M 485M 456M 415M 780M 53.73B 793M 5.34B 2.09B 26.91B 2.11B 2.06B 89.41B | P/E 2026 * |
-3.09x | P/E 2027 * | -6.73x |
|---|---|---|---|---|---|
| Enterprise Value | 562M 485M 456M 415M 780M 53.73B 793M 5.34B 2.09B 26.91B 2.11B 2.06B 89.41B | EV / Sales 2026 * |
4.25x | EV / Sales 2027 * | 2.87x |
| Free-Float |
83.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ARS Pharmaceuticals, Inc.
| 1 day | +2.21% | ||
| 1 week | -2.81% | ||
| Current month | +11.97% | ||
| 1 month | -17.94% | ||
| 3 months | -21.32% | ||
| 6 months | -38.76% | ||
| Current year | -50.70% |
| 1 week | 5 |  | 6.19 |
| 1 month | 4.91 | | 7.14 |
| Current year | 4.91 | | 13.15 |
| 1 year | 4.91 | | 15.09 |
| 3 years | 2.55 | | 18.9 |
| 5 years | 2.55 | | 18.9 |
| 10 years | 2.55 | | 18.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Donn Casale
CEO | Chief Executive Officer | 53 | 06/07/2026 |
Robert Bell
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2015 |
Kathleen Scott
DFI | Director of Finance/CFO | 57 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Pratik Shah
CHM | Chairman | 56 | 07/11/2022 |
Rajeev Dadoo
BRD | Director/Board Member | 55 | 31/07/2021 |
Saqib Islam
BRD | Director/Board Member | 56 | 30/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Free | Chief Executive Officer | 898,456 | 0.9048% | ||
| 24/06/26 | Free | Director | 30,000 | 0.0302% | ||
| 02/01/26 | Free | General Counsel | 240,000 | 0.2428% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.39% | -2.81% | -59.06% | -14.65% | 562M | |
| +0.64% | -2.55% | +1.62% | +19.36% | 48.42B | |
| +1.73% | -0.40% | +465.57% | +603.82% | 43.66B | |
| +3.21% | +0.17% | +12.62% | +87.02% | 39.51B | |
| -0.13% | -2.12% | +23.02% | +10.58% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +58.18% | 32.61B | |
| -1.39% | -4.89% | - | - | 16.32B | |
| +0.13% | -5.22% | +23.35% | +125.17% | 16.15B | |
| -0.62% | -0.06% | +3.95% | +27.74% | 14.16B | |
| +1.55% | +2.59% | +81.03% | +42.18% | 13.37B | |
| Average | +0.76% | -1.12% | +63.63% | +106.60% | 26.37B | |
| Weighted average by Cap. | +0.88% | -0.64% | +96.84% | +145.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 132M 114M 107M 97.64M 184M 12.65B 187M 1.26B 492M 6.33B 497M 486M 21.05B | 196M 169M 159M 144M 272M 18.71B 276M 1.86B 728M 9.37B 735M 719M 31.14B |
| Net income | -182M -157M -148M -134M -252M -17.4B -257M -1.73B -676M -8.71B -683M -668M -28.95B | -84.64M -73.11M -68.7M -62.48M -117M -8.09B -119M -805M -315M -4.05B -318M -311M -13.47B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | US$5.730 | +1.42% | 164,275 |
| 14/08/26 | US$5.650 | -7.38% | 5,046,019 |
| 13/08/26 | US$6.100 | +0.83% | 1,978,723 |
| 12/08/26 | US$6.050 | +1.68% | 1,314,029 |
| 11/08/26 | US$5.950 | +0.68% | 1,351,809 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRY Stock
Select your edition
All financial news and data tailored to specific country editions
